Status:
RECRUITING
Laser vs Hyaluronic Acid for GSM in Breast Cancer
Lead Sponsor:
Medical University of Graz
Conditions:
Urogenital Disease
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
All women from the outpatient department with a history of BC and GSM (genitourinary symptoms of menopause) symptoms will be invited to participate. After informed consent patients are either randomi...
Detailed Description
Device I- Laser The laser device is the Juliet feminine laser to treat women with SUI (Stress Urinary Incontinence), GSM and vaginal laxity. Asclepion' s headquarters are located in "Asclepion Laser T...
Eligibility Criteria
Inclusion
- Inclusion criteria
- genital symptoms of dryness/ burning/ irritation
- and/ or lack of lubrication during sexual intercourse/ sexual discomfort or pain
- and/or symptoms of urgency and dysuria or recurrent urinary tract infection
- Age 18-80
- History of BC and/ or DCIS
- Completed locoregional therapy
- Current antihormonal therapy for BC possible
- Intravaginal treatment with creams/ suppositories other than study medicationshould be ceased during the trial
- Exclusion criteria:
- Current or past genitourinary malignancy
- Abnormal PAP smear
- Current genitourinary tract infection
- Abnormal uterine bleeding
- photosensitive medication
Exclusion
Key Trial Info
Start Date :
January 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03816735
Start Date
January 24 2019
End Date
December 31 2024
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics, Medical University Graz
Graz, Austria, 8045